Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Nature. 2024 Apr 8. doi: 10.1038/s41586-024-07384-2. Online ahead of print.
Nature. 2024.
PMID: 38588696
Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer-A Review of Molecular Characterisation, Therapeutic Targets and Future Trends.
Pinilla K, Drewett LM, Lucey R, Abraham JE.
Pinilla K, et al. Among authors: drewett lm.
Front Oncol. 2022 Aug 8;12:866889. doi: 10.3389/fonc.2022.866889. eCollection 2022.
Front Oncol. 2022.
PMID: 36003779
Free PMC article.
Review.
Item in Clipboard
The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge.
Coles CE, Anderson BO, Cameron D, Cardoso F, Horton R, Knaul FM, Mutebi M, Lee N; Lancet Breast Cancer Commission.
Coles CE, et al.
Lancet. 2022 Mar 19;399(10330):1101-1103. doi: 10.1016/S0140-6736(22)00184-2. Epub 2022 Feb 18.
Lancet. 2022.
PMID: 35189077
No abstract available.
Item in Clipboard
Cite
Cite